Evangelia Emmanouilidou

Athens, ESYE31 11527, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Dysregulated proteostasis in p.A53T-α-Synuclein astrocytes aggravates Lewy-like neuropathology in a Parkinson's disease iPSC model.

Dysregulated proteostasis in p.A53T-α-Synuclein astrocytes aggravates Lewy-like neuropathology in a Parkinson's disease iPSC model.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 17, 2025

N-type Ca2+ channels mediate the stimuli-dependent α-synuclein secretion in mouse striatum.

N-type Ca2+ channels mediate the stimuli-dependent α-synuclein secretion in mouse striatum.

Journal: NPJ Parkinson's disease

Published: March 07, 2025

A Lipidomic Approach to Studying the Downregulation of Free Fatty Acids by Cytosolic Phospholipase A2 Inhibitors.

A Lipidomic Approach to Studying the Downregulation of Free Fatty Acids by Cytosolic Phospholipase A2 Inhibitors.

Journal: Biomolecules

Published: February 10, 2025

Aggregated α-synuclein in erythrocytes as a potential biomarker for idiopathic Parkinson's Disease.

Aggregated α-synuclein in erythrocytes as a potential biomarker for idiopathic Parkinson's Disease.

Journal: Parkinsonism & related disorders

Published: October 02, 2024

α-Synuclein in Parkinson's Disease: 12 Years Later.

α-Synuclein in Parkinson's Disease: 12 Years Later.

Journal: Cold Spring Harbor perspectives in medicine

Published: September 30, 2024

Ruthenium p-Cymene Complexes Incorporating Substituted Pyridine-Quinoline-Based Ligands: Synthesis, Characterization, and Cytotoxic Properties.

Ruthenium p-Cymene Complexes Incorporating Substituted Pyridine-Quinoline-Based Ligands: Synthesis, Characterization, and Cytotoxic Properties.

Journal: Molecules (Basel, Switzerland)

Published: May 29, 2024

First-Row Transition Metal Complexes Incorporating the 2-(2'-pyridyl)quinoxaline Ligand (pqx), as Potent Inflammatory Mediators: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and Thrombin.

First-Row Transition Metal Complexes Incorporating the 2-(2'-pyridyl)quinoxaline Ligand (pqx), as Potent Inflammatory Mediators: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and Thrombin.

Journal: Molecules (Basel, Switzerland)

Published: August 29, 2023

α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Cav3.2 calcium signaling in astrocytes.

α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Cav3.2 calcium signaling in astrocytes.

Journal: Translational neurodegeneration

Published: August 28, 2023

Assessment of Aggregated and Exosome-Associated α-Synuclein in Brain Tissue and Cerebrospinal Fluid Using Specific Immunoassays.

Assessment of Aggregated and Exosome-Associated α-Synuclein in Brain Tissue and Cerebrospinal Fluid Using Specific Immunoassays.

Journal: Diagnostics (Basel, Switzerland)

Published: May 25, 2023

Deficiency of the serine peptidase Kallikrein 6 does not affect the levels and the pathological accumulation of a-synuclein in mouse brain.

Deficiency of the serine peptidase Kallikrein 6 does not affect the levels and the pathological accumulation of a-synuclein in mouse brain.

Journal: Journal of neurochemistry

Published: November 19, 2019

High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases.

High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: October 19, 2019

Peripheral alpha-synuclein levels in patients with genetic and non-genetic forms of Parkinson's disease.

Peripheral alpha-synuclein levels in patients with genetic and non-genetic forms of Parkinson's disease.

Journal: Parkinsonism & related disorders

Published: September 22, 2019

Showing 1-12 of 30

Last Updated: 09/26/2026